The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized, placebo-controlled trial of atorvastatin to prevent hearing loss in patients with head and neck squamous cell carcinoma receiving cisplatin based chemoradiation (CRT).
 
Nicole C. Schmitt
Consulting or Advisory Role - Regeneron; Sensorion
Research Funding - Astex Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Patent pending for use of atorvastatin to prevent cisplatin-induced hearing loss
Travel, Accommodations, Expenses - KLS Martin; Regeneron
 
Katharine Fernandez
No Relationships to Disclose
 
Shawn Newlands
No Relationships to Disclose
 
Paul Allen
No Relationships to Disclose
 
Adam Kaufman
No Relationships to Disclose
 
Garnett P. McMillan
No Relationships to Disclose
 
Jeffrey M. Switchenko
No Relationships to Disclose
 
William A. Stokes
No Relationships to Disclose
 
Ranee Mehra
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Coherus Biosciences; Janssen Oncology; Merck KGaA
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Merck KGaA
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Anant Mandawat
No Relationships to Disclose
 
Robert Shamburek
No Relationships to Disclose
 
Nabil F. Saba
Honoraria - American Journal OF Managed Care; AstraZeneca; Coherus Biosciences; Eisai; EMD Serono; Exelixis; Fulgent Pharma; GlaxoSmithKline; Inovio Pharmaceuticals; Merck; Novartis; Taiho Pharmaceutical; TOSK; vaccinex
Consulting or Advisory Role - Akeso Biopharma; Fulgent Pharma; GlaxoSmithKline; Seagen
Research Funding - Bristol-Myers Squibb; Exelixis
Patents, Royalties, Other Intellectual Property - Springer textbook Royalty; Uptodate chapter writing and editing
Travel, Accommodations, Expenses - Merck
 
Lisa L. Cunningham
No Relationships to Disclose